雲南白藥(000538.SZ):擬斥15.5億元在閔行投建上海國際中心
格隆匯6月9日丨雲南白藥(000538.SZ)公佈,公司於2021年6月8日召開第九屆董事會2021年第五次會議,審議通過了《關於上海國際中心項目建設方案的議案》。
上海國際中心將定位於吸引高端人才、建立先進研發中心基地,培育新興業務板塊,逐步構建涵蓋研發、生產、市場推廣等業務發展平台。項目選址位於上海市閔行區南虹橋區域,根據項目土地價格、相關工程建設及設施設備的內容,預估項目總投資約15.5億元。
公司表示,設立雲南白藥上海國際中心,旨在快速引進國際一流的人才及項目資源,加強科研佈局,促進新產品、新業務和新產業的快速成長,提升改造現有的產業和業務結構,拉動公司全面高質量發展,實現做強做大新白藥的戰略目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.